Lisdexamfetamine and Methylphenidate Combination

The combination of lisdexamfetamine and methylphenidate is a therapeutic approach used primarily for treating Attention Deficit Hyperactivity Disorder (ADHD). This combination therapy involves using both medications together to potentially achieve better symptom control than either medication alone. Lisdexamfetamine (brand name Vyvanse) is a prodrug that converts to dextroamphetamine in the body. It blocks the reuptake of norepinephrine and dopamine into the presynaptic neuron and increases the release of these monoamines into the extraneuronal space[2]. Methylphenidate (brand name Ritalin) works similarly by affecting neurotransmitters in the brain, though through a slightly different mechanism. ## Medication Details **Canonical Names:** - Lisdexamfetamine: Available as Vyvanse - Methylphenidate: Available as Ritalin, Concerta, and other formulations **Dosage Forms:** - Lisdexamfetamine: Chewable tablets (10mg, 20mg, 30mg, 40mg, 50mg, 60mg) and oral capsules (10mg, 20mg, 30mg, 40mg, 50mg, 60mg, 70mg)[5][6] - Methylphenidate: Immediate-release tablets, extended-release tablets and capsules in various strengths[5][8][9] **Administration:** - Lisdexamfetamine: Usually taken once daily in the morning[6] - Methylphenidate: Depending on the formulation, may be taken 2-3 times daily (immediate-release) or once daily (extended-release)[8][9] ## Combination Therapy The combination of lisdexamfetamine and methylphenidate is not a standard first-line approach but may be used in specific cases where monotherapy doesn't provide adequate symptom control. Studies and clinical experience suggest that combination therapy may offer benefits: 1. **Enhanced Symptom Control**: Some patients experience better symptom reduction with combination therapy compared to either medication alone[3][4]. 2. **Extended Duration of Effect**: The combination may provide longer symptom coverage throughout the day[3]. 3. **Potential for Lower Stimulant Doses**: Some patients on combination therapy have been able to reduce their stimulant dosages substantially while maintaining or improving symptom control[4]. ## Clinical Evidence A study conducted by Wilens at Harvard in 2006 tested a combination of atomoxetine (a non-stimulant) and sustained-release methylphenidate, showing symptom reductions of more than 90% in patients who completed the study[3][4]. While this specific study didn't use lisdexamfetamine, it demonstrates the potential of combination approaches for ADHD. Clinical experience reported by physicians suggests that patients taking combinations of stimulants with other medications may experience: - Decreased side effects compared to high-dose stimulant monotherapy - Smoother transitions between medication effects - Improved family functioning with fewer "meltdowns" as medications wear off[4] ## Safety Considerations When combining lisdexamfetamine and methylphenidate, there is a moderate drug interaction potential[1]. Both medications are stimulants and can have additive effects on: - Blood pressure - Heart rate - Central nervous system stimulation Careful monitoring and dose adjustment are essential when using this combination to minimize side effects while maximizing therapeutic benefit.